Evidence map›Paper›PMID 22156432›Full record

ArticleApplied and environmental microbiology2012

CTX-M-15 extended-spectrum β-lactamase in a shiga toxin-producing Escherichia coli isolate of serotype O111:H8.

Charlotte Valat, Marisa Haenni, Estelle Saras, Frédéric Auvray, Karine Forest, Eric Oswald, Jean-Yves Madec

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Genomic Epidemiology of Shiga Toxin-ProducingAnimals : an open access journal from MDPI · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Antibiotic resistance and integrons in Shiga toxin-producing Escherichia coli (STEC).Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2015
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Charlotte ValatUnité Antibiorésistance et Virulence Bactériennes, ANSES Site de Lyon, Lyon, France. charlotte.valat@anses.fr
Marisa Haenni
Estelle Saras
Frédéric Auvray
Karine Forest
Eric Oswald
Jean-Yves Madec
Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRHôpital Purpan · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the discovery of a CTX-M-15-producing Escherichia coli (STEC) of serogroup O111:H8, a major serotype responsible for human enterohemorrhagic Escherichia coli (EHEC) infections. In line with the recent CTX-M-15/O104:H4 E. coli outbreak, these data may reflect an accelerating spread of resistance to expanded-spectrum cephalosporins within the E. coli population, including STEC isolates.

Indexed as

Anti-Bacterial Agentsbeta-Lactamasesbeta-Lactam ResistanceCephalosporinsEscherichia coli InfectionsHumansSerotypingShiga-Toxigenic Escherichia coliAnti-Bacterial Agentsbeta-lactamase CTX-M-15beta-LactamasesCephalosporins

Identifiers

PMID22156432
PMCPMC3273006
OpenAlexW1997106149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.